Hussman Strategic Advisors, Inc. Haemonetics Corp Transaction History
Hussman Strategic Advisors, Inc.
- $428 Million
- Q3 2025
A detailed history of Hussman Strategic Advisors, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 10,500 shares of HAE stock, worth $528,990. This represents 0.12% of its overall portfolio holdings.
Number of Shares
10,500Holding current value
$528,990% of portfolio
0.12%Shares
1 transactions
Others Institutions Holding HAE
# of Institutions
331Shares Held
53.3MCall Options Held
304KPut Options Held
77.8K-
Black Rock Inc. New York, NY5.96MShares$300 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.95MShares$250 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.28MShares$215 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA2.15MShares$108 Million0.03% of portfolio
-
State Street Corp Boston, MA1.88MShares$94.9 Million0.01% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $2.59B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...